Orlistat ameliorates lipid dysmetabolism in high-fat diet-induced mice via gut microbiota modulation
Orlistat reduces obesity by inhibiting gastrointestinal lipases, thereby blocking the absorption and accumulation of triglycerides in the intestine. It has been shown to improve lipid metabolism and alter intestinal microbial communities in animals and humans. However, the impact of Orlistat-induced...
Saved in:
Main Authors: | Chengyan Huang, Yuanhui He, Ping Chai, Zongxin Liu, Sirui Su, Yanhui Zhang, Yuelan Luo, Shuiping Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1480500/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimicrobial peptide AP2 ameliorates Salmonella Typhimurium infection by modulating gut microbiota
by: Lianglan Li, et al.
Published: (2025-02-01) -
High-dose thiamine supplementation ameliorates obesity induced by a high-fat and high-fructose diet in mice by reshaping gut microbiota
by: Yu Xia, et al.
Published: (2025-02-01) -
Sargassum fusiforme and its fucoidan alleviates high-fat diet induced obesity associated with the improvement of the gut microbiota profile
by: Xiaoyu Ling, et al.
Published: (2025-02-01) -
Fecal microbiota transplantation alleviates radiation enteritis by modulating gut microbiota and metabolite profiles
by: Qin Ding, et al.
Published: (2025-02-01) -
Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis
by: Keyu Ren, et al.
Published: (2025-02-01)